Crescita Therapeutics Inc.
CRRTF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $8,933 | $6,105 | $10,679 | $12,444 |
| - Cash | $8,308 | $8,184 | $8,538 | $9,273 |
| + Debt | $484 | $602 | $718 | $834 |
| Enterprise Value | $1,109 | -$1,477 | $2,859 | $4,005 |
| Revenue | $5,393 | $6,233 | $3,537 | $6,902 |
| % Growth | -13.5% | 76.2% | -48.8% | – |
| Gross Profit | $2,855 | $3,825 | $1,747 | $2,995 |
| % Margin | 52.9% | 61.4% | 49.4% | 43.4% |
| EBITDA | $1,147 | $1,163 | -$567 | $204 |
| % Margin | 21.3% | 18.7% | -16% | 3% |
| Net Income | $753 | $798 | -$932 | -$162 |
| % Margin | 14% | 12.8% | -26.4% | -2.3% |
| EPS Diluted | 0.04 | 0.04 | -0.05 | -0.008 |
| % Growth | 0% | 180% | -495.2% | – |
| Operating Cash Flow | $1,173 | -$3 | -$513 | $1,376 |
| Capital Expenditures | -$46 | -$170 | -$66 | -$353 |
| Free Cash Flow | $1,127 | -$173 | -$579 | $1,023 |